查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1458415

全球精准医疗市场：依用途、依应用、依技术、依最终用户、依地区、机会、预测，2017-2031 年

Precision medicine Market Assessment, By Use, By Application, By Technology, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 223 Pages | 商品交期: 3-5个工作天内

价格

全球精准医疗市场规模预计将从2023年的516.9亿美元成长到2031年的1,086.1亿美元，在2024-2031年的预测期间内复合年增长率为9.73%。影响全球精准医疗市场的因素有很多。这包括对研究的日益重视、精准医学在慢性病中的广泛使用、癌症治疗的创新、诊断的使用增加以及精准医学平台的日益普及。

对研究的日益关注正在对精准医疗的全球市场占有率产生重大影响。资助基因组中心产生精准医学所必需的遗传数据是精准医学计画 (PMI) 等计画刺激创新的一种方式。该研究领域改进了客製化治疗策略。精准医疗正在彻底改变癌症治疗，这也是全球精准医疗市场成长的主要动力。精准医疗提高早期发现及治疗效果。透过使用基因定序和个人化诊断等尖端技术，诊断中对精准医学不断增长的需求正在改善疾病识别和管理。

全球精准医疗市场规模也受到精准医疗在慢性病治疗中广泛应用的影响。透过根据每位患者独特的基因谱和疾病特征量身订做治疗方案，精准医疗正在彻底改变慢性病治疗的方式。这种个人化的方法提高了治疗效果。精准医学也广泛应用于癌症治疗，因为它有助于开发更精确、更有效的治疗方法。这种方法可以改善患者的治疗效果和照护。精准医疗平台的日益接受度正在显着影响全球精准医疗市场的成长。精准医疗平台可以实现早期干预和可能挽救生命的治疗，将重点从被动医疗保健转向预防性医疗保健。透过根据患者的基因组成、生活方式和周围环境创建个人化治疗方案，这些平台可以改善患者的治疗结果。它还减少了反覆试验的需要，促进了具有成本效益的护理，并改善了临床结果。

该报告审视了全球精准医疗市场，并提供了市场概述，包括依使用、应用、技术、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第一章研究方法论

第二章 专案范围与定义

第三章执行摘要

第四章 2017-2031年全球精准医疗市场前景

  • 市场规模及预测
  • 依用途
  • 依用途
  • 依技术
  • 依最终用户
  • 依地区
  • 依公司划分的市占率 (%)，2023 年

第 5 章 2017-2031 年全球精准医疗市场前景（依地区）

  • 北美
  • 欧洲
  • 南美洲
  • 中东/非洲

第六章 2023 年市场规划

第七章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

第九章 监理架构与创新

第十章 主要与企业状况

第11章价格分析

第十二章案例研究

第十三章 主要进入者展望

  • Moderna Inc
  • BioMerieux SA
  • Bayer AG
  • Novartis AG
  • Pfizer Inc
  • AstraZeneca plc
  • GSK plc
  • Biogen Inc
  • F. Hoffmann-La Roche AG
  • Merck &Co. Inc

第十四章 战略建议

第十五章 查询及免责声明

Product Code: MX11212

The global precision medicine market is projected to witness a CAGR of 9.73% during the forecast period 2024-2031, growing from USD 51.69 billion in 2023 to USD 108.61 billion in 2031. Various factors shape the global precision medicine market. These include an increased focus on research, extensive use of precision medicine in chronic diseases, revolutionizing treatment for cancer, increasing use in diagnostics, and growing popularity of precision medicine platforms.

The increased focus on research has a significant impact on the global precision medicine market share. Funding genome centers to produce essential genetic data for precision medicine is one way that programs like the Precision Medicine Initiative (PMI) stimulate innovation. This area of study improves customized treatment strategies. The way precision medicine is revolutionizing cancer treatment is also substantially bolstering the growth of the global precision medicine market. Precision medicine enhances the effectiveness of early detection and therapy. Through the use of cutting-edge technology like gene sequencing and personalized diagnostics, the growing demand for precision medicine in diagnostics is improving disease identification and management.

The global precision medicine market size has also been affected by the extensive use of precision medicine in treating chronic diseases. By customizing treatments to each patient's unique genetic profile and illness characteristics, precision medicine is revolutionizing the way chronic disease care is provided. This individualized approach enhances the results of treatment. Precision medicine is extensively used in treating cancer as it helps in developing more precise and effective therapeutics. Both patient outcomes and care are improved by this method. The growing acceptance of precision medicine platforms greatly impacts the global precision medicine market growth. Precision medicine platforms enable early interventions and potentially life-saving procedures by shifting the focus from reactive to preventative healthcare. By allowing the creation of individualized treatment regimens based on a patient's genetic composition, way of life, and surroundings, these platforms improve patient outcomes. They also reduce the need for trial-and-error methods, promote cost-effective care, and enhance clinical results.

Frederick Health, a top healthcare organization with its main office located in Frederick County, Maryland, decided to improve its precision medicine program on February 27, 2024, by integrating GenomOncology's Precision Oncology Platform with the industry-leading MEDITECH Expanse Genomics solution.

Increased Focus on Precision Medicine Research

One of the major global precision medicine market trends is the heightened emphasis on precision medicine research. Research projects like the Precision Medicine Initiative (PMI) provide funding to genome centers so they can produce the vital genomic data needed for customized therapeutic strategies. The creation of individualized treatment programs based on a patient's genetic composition, way of life, and surroundings is made possible by this study area, improving patient results. Important breakthroughs in precision medicine, such as single nucleotide polymorphism and microarray/biochips, are driving advances in cancer biologics and revolutionizing therapeutic approaches, which, in turn, is fueling the global precision medicine market growth. The human genome is still being studied, and this research has the potential to change medical practices and enhance patient care. This is where precision medicine is headed.

On February 13, 2024, the University of Sydney in Australia announced a five-year research agreement with Bruker, a world-renowned maker of high-performance scientific instruments, marking a significant advancement in precision medicine. As part of the collaboration, the University will get two Bruker atomic force microscopes to expand its top-notch research infrastructure. This month, the next generation of microscopes will be installed.

Extensive Use of Precision Medicine in Chronic Diseases

One major factor fueling the growth of the global precision medicine market is the widespread application of precision medicine in the treatment of chronic illnesses. By customizing medicines to each patient's unique genetic profile and illness characteristics, precision medicine is revolutionizing treatment approaches for chronic diseases, such as cancer, cardiovascular disease, and neurological disorders. Improved patient outcomes result from this tailored strategy, which also reduces side effects and increases therapeutic efficacy. The aging population and the increasing incidence of chronic diseases globally are driving the need for precision medicine in diagnostics and treatments, which is propelling the growth of the global precision medicine market. The focus of healthcare is shifting from reactive to preventative strategies for better health outcomes, owing to precision medicine's capacity to identify patients at higher risk of developing specific diseases early on, enabling preventive actions.

In June 2023, the Oxford Endometriosis Gene (OXEGENE) dataset was licensed to PrecisionLife, a premier biotech company that is advancing precision medicine in complex chronic diseases. This enabled PrecisionLife to create novel, individualized medicines for endometriosis patients. Ten percent of women worldwide are affected with endometriosis, a chronic illness that causes excruciating agony and infertility.

Revolutionizing Treatment for Cancer

One of the main factors propelling the growth of the global precision medicine market is the widespread application of precision medicine in cancer therapy. As more oncologists use precision medicine to treat patients based on their genetic profiles, the market is growing because of the increased availability of more focused and efficient cancer medicines. When compared to normal treatments, precision medicine's customized medicines based on each patient's unique genetic profile and disease features have the potential to shorten side effects and speed up recovery. Precision medicine advancements, including molecular testing in cancer care, allow doctors to choose treatments that maximize beneficial side effects and increase survival rates, which propels market growth.

To boost Moderna's cancer ambitions, the precision medicine startup Caris Life Science, which focuses on artificial intelligence, collaborated with Moderna in October 2023. Moderna's cancer pipeline will be advanced by using Caris's deidentified data library as part of its multiyear agreement. The collaboration will also concentrate on identifying novel biomarkers, improving clinical trial design, and characterizing resistance mechanisms.

Increasing Use in Diagnostics

These days, image-based diagnostics make extensive use of precision medicine, which is greatly fueling the expansion of the global precision medicine market. By considering each patient's distinct genetic and molecular composition, way of life, and environmental influences, this method tailors illness prevention and therapy. By choosing and implementing the best diagnosis and treatment options for each patient, precision medicine in clinical practice seeks to minimize iatrogenic harm, medical costs, and patient benefits. The use of biomarkers is fundamental to customized diagnosis and treatment. Customized diagnosis and treatment are integrated with image-based invasive intervention.

In January 2024, Merck KGaA, a multinational science and technology firm based in Germany, and Quibim, a business that turns imaging data into actionable forecasts of cancer development and therapy responses, collaborated to develop the next generation of image-based diagnostics for precision medicine.

North America Dominating the Market

With a significant revenue share of more than 40%, North America dominates the global precision medicine market. The region's large investments in precision medicine projects, especially in oncology-targeted treatments, and the rising demand for precision medicine applications are acknowledged as contributing causes to this leadership position. The existence of significant industry leaders reinforces North America's predominant position in the advancement and use of precision medicine. The area also leads the precision medicine sector in terms of innovation and growth because of its substantial R&D investments and sophisticated hospital infrastructure.

The US state of California will have a precision medicine center thanks to cooperation announced in January 2024 by Bios Health, a leader in the development of AI-driven precision medicine for the nervous system, with the city of Bakersfield and the Kern Venture Group. Using adaptive dosage technology from BIOS, the facility will function as a center for neurological clinical studies and research and development (R&D).

Future Market Scenario (2024 - 2031F)

To provide patients with personalized medication, health systems are combining several platforms, such as artificial intelligence and data analytics software. Such ventures are driving the growth of the global precision medicine market.

The global precision medicine market will advance with the development of novel diagnostics and biomarkers since doctors will be better equipped to find targeted treatments for a wider range of causes.

In the future, the use of immunotherapy and new diagnostic and bioinformatics tools will propel the expansion of the global precision medicine market.

The growing emphasis on molecular testing to enhance prognosis, therapeutic decision-making, and outcomes will drive growth in the global precision medicine market.

Key Players Landscape and Outlook

Leading businesses in the global precision medicine market are aggressively forming alliances to improve their skills and methodologies. The growth of the market is being propelled by partnerships, which facilitate the diversification of product offerings, augment R&D endeavors, and stimulate technological innovation in precision medicine. By facilitating the sharing of knowledge, resources, and technology, these strategic alliances help to build increasingly sophisticated precision medicine solutions. Companies can improve their market position, quicken the pace of product development, and successfully meet changing healthcare demands by utilizing partnerships.

For instance, on February 27, 2024, Owkin, a biotech company that advances personalized medicine by fusing human and AI tools, announced a partnership with Amazon Web Services (AWS) to transform drug discovery, accelerate clinical trials, and create AI-driven diagnostics. Through this agreement, Owkin's data handling will be improved, operational efficiency will be maximized, and research into precision medicine will be advanced by utilizing AWS's vast global infrastructure and cloud capabilities.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Precision Medicine Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Use
    • 4.2.1.Diagnostics
    • 4.2.2.Therapeutics
  • 4.3.By Application
    • 4.3.1.Central Nervous System
    • 4.3.2.Respiratory
    • 4.3.3.Immunology
    • 4.3.4.Oncology
    • 4.3.5.Others
  • 4.4.By Technology
    • 4.4.1.Point-of-care Testing
    • 4.4.2.Stem Cell Therapy
    • 4.4.3.Pharmacogenomics
    • 4.4.4.Pharmacoproteomics
    • 4.4.5.Others
  • 4.5.By End-user
    • 4.5.1.Pharmaceutical Companies
    • 4.5.2.Diagnostic Companies
    • 4.5.3.Healthcare IT Companies
    • 4.5.4.Others
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.Europe
    • 4.6.3.Asia-Pacific
    • 4.6.4.South America
    • 4.6.5.Middle East and Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Precision Medicine Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Use
      • 5.1.2.1.Diagnostics
      • 5.1.2.2.Therapeutics
    • 5.1.3.By Application
      • 5.1.3.1.Central Nervous System
      • 5.1.3.2.Respiratory
      • 5.1.3.3.Immunology
      • 5.1.3.4.Oncology
      • 5.1.3.5.Others
    • 5.1.4.By Technology
      • 5.1.4.1.Point-of-care Testing
      • 5.1.4.2.Stem Cell Therapy
      • 5.1.4.3.Pharmacogenomics
      • 5.1.4.4.Pharmacoproteomics
      • 5.1.4.5.Others
    • 5.1.5.By End-user
      • 5.1.5.1.Pharmaceutical Companies
      • 5.1.5.2.Diagnostic Companies
      • 5.1.5.3.Healthcare IT Companies
      • 5.1.5.4.Others
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
      • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Use
      • 5.1.6.2.1.Diagnostics
      • 5.1.6.2.2.Therapeutics
      • 5.1.6.3.By Application
      • 5.1.6.3.1.Central Nervous System
      • 5.1.6.3.2.Respiratory
      • 5.1.6.3.3.Immunology
      • 5.1.6.3.4.Oncology
      • 5.1.6.3.5.Others
      • 5.1.6.4.By Technology
      • 5.1.6.4.1.Point-of-care Testing
      • 5.1.6.4.2.Stem Cell Therapy
      • 5.1.6.4.3.Pharmacogenomics
      • 5.1.6.4.4.Pharmacoproteomics
      • 5.1.6.4.5.Others
      • 5.1.6.5.By End-user
      • 5.1.6.5.1.Pharmaceutical Companies
      • 5.1.6.5.2.Diagnostic Companies
      • 5.1.6.5.3.Healthcare IT Companies
      • 5.1.6.5.4.Others
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Use
  • 6.2.By Application
  • 6.3.By Technology
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Moderna Inc
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.BioMerieux SA
  • 13.3.Bayer AG
  • 13.4.Novartis AG
  • 13.5.Pfizer Inc
  • 13.6.AstraZeneca plc
  • 13.7.GSK plc
  • 13.8.Biogen Inc
  • 13.9.F. Hoffmann-La Roche AG
  • 13.10.Merck & Co. Inc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 4.Global Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 5.Global Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 6.Global Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Precision Medicine Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 11.North America Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 12.North America Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 13.North America Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Precision Medicine Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 18.United States Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 19.United States Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 20.United States Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 24.Canada Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 25.Canada Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 26.Canada Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 30.Mexico Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 31.Mexico Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 32.Mexico Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 36.Europe Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 37.Europe Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 38.Europe Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Precision Medicine Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 43.Germany Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 44.Germany Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 45.Germany Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 49.France Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 50.France Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 51.France Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 55.Italy Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 56.Italy Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 57.Italy Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 61.United Kingdom Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 62.United Kingdom Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 63.United Kingdom Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 67.Russia Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 68.Russia Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 69.Russia Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 73.Netherlands Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 74.Netherlands Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 75.Netherlands Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 79.Spain Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 80.Spain Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 81.Spain Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 85.Turkey Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 86.Turkey Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 87.Turkey Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 91.Poland Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 92.Poland Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 93.Poland Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 97.South America Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 98.South America Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 99.South America Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Precision Medicine Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 104.Brazil Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 105.Brazil Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 106.Brazil Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 110.Argentina Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 111.Argentina Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 112.Argentina Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 116.Asia-Pacific Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 117.Asia-Pacific Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 118.Asia-Pacific Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Precision Medicine Market Share (%), By Country, 2017-2031F
  • Figure 120.India Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 123.India Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 124.India Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 125.India Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 129.China Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 130.China Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 131.China Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 135.Japan Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 136.Japan Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 137.Japan Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 141.Australia Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 142.Australia Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 143.Australia Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 147.Vietnam Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 148.Vietnam Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 149.Vietnam Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 153.South Korea Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 154.South Korea Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 155.South Korea Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 159.Indonesia Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 160.Indonesia Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 161.Indonesia Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 165.Philippines Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 166.Philippines Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 167.Philippines Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 171.Middle East & Africa Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 172.Middle East & Africa Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 173.Middle East & Africa Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Precision Medicine Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 178.Saudi Arabia Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 179.Saudi Arabia Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 180.Saudi Arabia Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 184.UAE Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 185.UAE Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 186.UAE Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Precision Medicine Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Precision Medicine Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Precision Medicine Market Share (%), By Use, 2017-2031F
  • Figure 190.South Africa Precision Medicine Market Share (%), By Application, 2017-2031F
  • Figure 191.South Africa Precision Medicine Market Share (%), By Technology, 2017-2031F
  • Figure 192.South Africa Precision Medicine Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Use Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023